Healthequity Inc (HQY) FinancialsHQYHealthequity Inc

Evaluating the bottom line, HealthEquity, Inc. maintains a gross margin of 66.05%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 28.42%, while the net margin is 18.72%. These profitability ratios, combined with a Return on Equity (ROE) of 11.43%, provide a clear picture of how effectively HQY converts its operational activities into shareholder value.

In the context of the broader market, HQY competes directly with industry leaders such as VCTR and CIGI. With a market capitalization of $7.66B, it holds a leading position in the sector. When comparing efficiency, HQY's gross margin of 66.05% stands against VCTR's 84.25% and CIGI's 35.83%. Such benchmarking helps identify whether HealthEquity, Inc. is trading at a premium or discount relative to its financial performance.

HealthEquity has shown strong financial performance with a gross margin of 66.05% and a net income of $69.4 million for Q1 2027, reflecting robust profitability and operational efficiency. The company also reported a significant increase in revenue, with Q2 revenue at $350.7 million, an 8% year-over-year growth.